irbmed contacts and roster
man in lab coat using computer in room with people

During business hours, please call our office at (734) 763-4768 or email irbmed@umich.edu, or contact IRBMED staff directly. Chairs are on-call to address emergencies related to research with human participants at all hours. 

IRBMED Roster
IRBMED Staff
Designated Chairs On Call

If you have an emergency related to human subject research and need to reach the IRBMED, please call our office during business hours at (734) 763-4768. After hours, please call the U-M operator at (734) 936-4000 and ask them to page the designated Chair on call. 

IRBMED Chairs On Call Determination Instructions
In the event of an emergency related to human research subject safety, attempt to contact the Chair on call first. If they are not available, contact the alternate Chair on call.

MonthCHAIR ON CALLALTERNATE CHAIR ON CALL
October 2024Geisser, Michael
0069 on page
Davenport, Robertson (Rob)
2982 on page
November 2024Davenport, Robertson (Rob)
2982 on page
Filbrun, Amy
14598 on page
December 2024Filbrun, Amy
14598 on page
Geisser, Michael
0069 on page
January 2025Geisser, Michael
0069 on page
Davenport, Robertson (Rob)
2982 on page


In the event you cannot reach the Chair on call or the designated alternate, then call one of the alternate Vice Chairs listed below, proceeding in alphabetical order. (If you cannot reach one of the representatives below by their pagers, please call the paging operator, identify yourself, and request to be transferred to the appropriate Chair's home telephone number.)

  1. MacDonald Dick: 1863
  2. Kevin Flaherty: 10505
Emergencies & Additional Resources

Examples of emergency situations include (but are not limited to):

  • A serious, research-related unanticipated problem that requires immediate IRB attention
  • “Emergency use” (i.e., treatment) of a patient with an agent unapproved by the FDA when that treatment must commence within 24 hours
  • Enrollment of a ward of the state on a study approved under 45 CFR 46.406 or 407.
  • Enrollment of a patient who is also a prisoner onto a research trial (when the study has not been previously approved under the prisoner regulations and certified with OHRP). See “Subject Incarceration” guidance for more information.
  • Health and well-being reasons to continue a research intervention on a subject who becomes incarcerated (when the study has not been previously approved under the prisoner regulations and certified with OHRP). See “Subject Incarceration” guidance for more information.

Additional Resources

NCRC Maps and Directions webpage

The University of Michigan Registrations with FDA and OHRP

The University of Michigan's Institutional Review Boards (IRBs) are registered with the HHS Office of Human Research Protections and, in compliance with the new HHS Food and Drug Administration (FDA) rule issued on July 14, 2009, with FDA.

FDA’s new requirement operates in coordination with the Office for Human Research Protections (OHRP), which already requires registration for IRBs reviewing federally-supported research.  A single database of all U.S. IRBs, regardless of whether they review research regulated by FDA or other federal agencies, has been established.

Registration information can be accessed via the HHS Registration page. In the search field "Institution/Organization" enter "U of Michigan" to verify UM registration.

If you have any questions about this information please contact the IRBMED Office.

Contact the Paging Operator

IRBMED Staff

Senior Staff

NameTitle
Kindra Cooper, JDDirector
Amy Skyles, PharmDAssistant Director
Bethany Vibbart, MS, CIPAssistant Director

Support Staff

NameTitle
David Andrews, BA, MABoard Secretary
Patti MeredithReceptionist

Specialized Coordinators

NameTitle
Jill Baker, MSW, MATechnical Writer (Meeting Minutes)
Cecilia Brenner, CIPsIRB Ceding Applications
Catherine Dowling, MD, CCRPPrincipal Associate Regulatory Analyst
Angela Faber, BS, CIPSenior Associate Regulatory Analyst
Jennifer Galland, MHA, CIPPrincipal Associate Regulatory Analyst
Megan Halvorson, BS, CCRPIntermediate Associate Regulatory Analyst
Randall McCombs, MSIArchival Specialist
Christine Poulsen, MLAEducation Coordinator
Nicole Robson, MHAsIRB Accepting/Authorization Agreements
Brian Seabolt, BASenior Technical Writer
Cameron Shultz, Ph.D., MSWSenior Research Compliance Specialist
Lark Speyer, BS, CIPCoordinator

Expedited Review Regulatory Team

NameTitle
Carla Butler, BA, CCRPIntermediate Associate Regulatory Analyst
Nitya Chandran, Ph.D.Intermediate Associate Regulatory Analyst
Lori Cooper, MAIntermediate Associate Regulatory Analyst
Ann Dillon, BS, CIPExpedited Team Lead
Jessica Harless, MPH, CCRPIntermediate Associate Regulatory Analyst
Allison Kanous, BS, CIPIntermediate Associate Regulatory Analyst
Karen King, BAIntermediate Associate Regulatory Analyst
Liz LeMay, MBAIntermediate Associate Regulatory Analyst
Sharmi Purkayestha, MSIntermediate Associate Regulatory Analyst
Amanda Rasnake, BSN, RN, CCRPIntermediate Associate Regulatory Analyst
Markeda Richards, BSIntermediate Associate Regulatory Analyst
Samantha Scheer, BAIntermediate Associate Regulatory Analyst
Monica ScottJunior Associate Regulatory Analyst

Full-Board Regulatory Team

NameTitle
Megan Boyt, M.Ed., CIPSenior Associate Regulatory Analyst
Neale Danridge, MBAIntermediate Associate Regulatory Analyst
Carol Hutsko, BBA, CIPSenior Associate Regulatory Analyst
Julia Ryan, MS, RD, LD, CIPSenior Associate Regulatory Analyst
Monica Stiddom, BA, CIPSenior Associate Regulatory Analyst
Wendy Ulmer, BBASenior Associate Regulatory Analyst

Board Co-Chairs & Vice-Chairs

NameTitlePager Number
Robertson Davenport, M.D.Co-Chair C1/C22982
Amy Filbrun, M.D.Co-Chair A1/B214598
Michael Geisser, Ph.D.Co-Chair A2/B10069
Ghada Abusin, M.D.Vice-Chair C121587
James Balter, M.D.Vice-Chair A18670
Macdonald Dick, M.D.Vice-Chair A21863
Robert Eber, DDS, MSVice-Chair B1 
Kevin Flaherty, M.D.Vice-Chair B210505
Anne Schott, M.D.Vice-Chair C23943


September 2024 IRBMED Roster

We're Accredited

IRBMED has full accreditation by they Association for the Accreditation of Human Research Protection Programs, Inc.

Learn More